Vascular actions of insulin with implications for endothelial dysfunction.
about
Role of insulin in the type 2 diabetes therapy: past, present and futureAdverse cardiovascular outcomes between insulin-treated and non-insulin treated diabetic patients after percutaneous coronary intervention: a systematic review and meta-analysisCardiovascular effects of basal insulinsInsulin resistance as a physiological defense against metabolic stress: implications for the management of subsets of type 2 diabetesImpact of type 2 diabetes mellitus on the long-term mortality in patients who were treated by coronary artery bypass surgery: A systematic review and meta-analysis.Concomitant therapy with pioglitazone and insulin for the treatment of type 2 diabetesInsulin transcriptionally regulates argininosuccinate synthase to maintain vascular endothelial function.Vascular biology of metabolic syndromeClinical Update: Cardiovascular Disease in Diabetes Mellitus: Atherosclerotic Cardiovascular Disease and Heart Failure in Type 2 Diabetes Mellitus - Mechanisms, Management, and Clinical ConsiderationsEuglycemic hyperinsulinemia increases blood pressure in pregnant rats independent of placental antiangiogenic and inflammatory factors.Metabolic syndrome is associated with type II endoleak after endovascular abdominal aortic aneurysm repair.Reduction of large-conductance Ca²(+) -activated K(+) channel with compensatory increase of nitric oxide in insulin resistant rats.Acute and sustained actions of hyperglycaemia on endothelial and glomerular barrier permeability.Examining the role of insulin in the regulation of cardiovascular health.The IGF-1 receptor and regulation of nitric oxide bioavailability and insulin signalling in the endothelium.The role of endothelial insulin signaling in the regulation of glucose metabolism.Molecular biology of atherosclerosis.The cardiovascular effects of insulin.The impact of insulin resistance on the kidney and vasculature.Small Vessels, Big Role: Renal Microcirculation and Progression of Renal Injury.Insulin resistance may contribute to vascular dysfunction in patients with chronic obstructive pulmonary disease.The effect of tumour necrosis factor-α and insulin on equine digital blood vessel function in vitro.Insulin signaling to the glomerular podocyte is critical for normal kidney function.Hyperinsulinemia may have a protective role in the early stages of atherosclerosis in rabbit model of hypercholesterolemia.Insulin and Its Cardiovascular Effects: What Is the Current Evidence?Chronic placental ischemia alters amniotic fluid milieu and results in impaired glucose tolerance, insulin resistance and hyperleptinemia in young rats.Endothelin-1 contributes to endothelial dysfunction and enhanced vasoconstriction through augmented superoxide production in penile arteries from insulin-resistant obese rats: role of ET(A) and ET(B) receptors.Insulin-stimulated phosphorylation of endothelial nitric oxide synthase at serine-615 contributes to nitric oxide synthesis.Improvement of β-cell function after achievement of optimal glycaemic control via long-term continuous subcutaneous insulin infusion therapy in non-newly diagnosed type 2 diabetic patients with suboptimal glycaemic control.Cardiovascular safety of insulin: Between real-world data and reality.Pulmonary vascular effect of insulin in a rodent model of pulmonary arterial hypertension.Hypertension and Diabetes Mellitus: Coprediction and Time Trajectories.Obesity, type 2 diabetes, and impaired insulin-stimulated blood flow: role of skeletal muscle NO synthase and endothelin-1.Insulin induces the correlation between renal blood flow and glomerular filtration rate in diabetes: implications for mechanisms causing hyperfiltration.Protective Role of Perivascular Adipose Tissue in Endothelial Dysfunction and Insulin-Induced Vasodilatation of Hypercholesterolemic LDL Receptor-Deficient Mice.Dysfunction of human subcutaneous fat arterioles in obesity alone or obesity associated with Type 2 diabetes.Aquaporin Membrane Channels in Oxidative Stress, Cell Signaling, and Aging: Recent Advances and Research Trends.Insulin-Stimulated Bone Blood Flow and Bone Biomechanical Properties Are Compromised in Obese, Type 2 Diabetic OLETF RatsDeterminants of evolving metabolic and cardiovascular benefit/risk profiles of rosiglitazone therapy during the natural history of diabetes: molecular mechanisms in the context of integrated pathophysiology
P2860
Q22241148-3C773E3A-20FD-4077-B3D8-416557FC567CQ26786265-4F0B448E-3838-44E7-A1C4-506CB3835DB7Q26800249-C019BC4D-529C-4CF7-834D-28FD60DD68BEQ26866924-6B16B00D-ECF2-4EE6-A6E5-CA995587B0D0Q33765509-5DA1AEDA-BAFF-4C76-9F4A-25BF22F7A579Q33797616-EC21D8E9-EC3C-4A98-9E58-86EB364C96CAQ34181615-FDC854BC-75E0-47F4-A9F9-54FA1D771834Q35106315-8CC166F0-EDE0-422C-863B-9C288C027843Q37011769-FFBB6E72-25EB-44F9-98B7-1D17FAAF7A32Q37277237-6CF16533-D147-4678-904F-B7F870A5D66EQ37666027-BBF5A749-D59A-45DD-AFDB-14BEA81F5A01Q37855745-839FE81B-5AE6-4020-B3D1-19BC6B5743E3Q37910988-AC3E583E-46A8-40CD-8C50-4BEAF5839295Q38069198-2AEC27F0-1C6F-4D9A-B671-58C52DA72F5FQ38075845-6E77DA31-2A27-4367-9BE5-CCB1C9B4A5B8Q38099275-437D4AF9-E206-4E5B-9AFE-1310B5F7B41DQ38125279-7D1C86B4-6A52-41D9-BE33-1BE1082D22B1Q38217755-C40C3953-7AD0-4DB6-B94D-0D26732BF235Q38982413-D07C8B41-7C8B-4008-9B0F-81927148D6FAQ39134052-462A14A8-7282-4110-96BF-E656D01D58A1Q40158270-F00D03B7-D308-4526-8ADB-93C761B7DFD0Q40186727-EA0B5BD8-926C-4C07-A743-1BAB82E783CCQ42110064-05E619F3-7974-4704-82A6-46E8FAA16EDFQ42183640-D8450F9D-479D-433E-8418-964DB3BB0DAAQ42517257-F472E2E2-DEF0-4651-861D-46EDB5E7A975Q43014003-808E7F55-E498-4C3E-BEF0-5AA3C248F6B0Q43101498-7435578F-3AC2-49DC-9A4F-492C44D66921Q43238697-13CCC3E5-2A46-4C05-BD7A-007B3C76F491Q44598061-C83266FC-B69F-4FA8-B0F5-7BA764BCA434Q45895265-EECFED3F-E26A-46A4-9658-4536B6CF930FQ46336560-C1AFBEB3-8782-4D32-86DB-EC63A9A64142Q50043473-C106B446-2BE2-4CC9-8E96-7A6241068344Q50333291-83858F6F-A148-4747-83B0-CBBE398B54FAQ53176722-E0EBC2CC-3C3A-411F-9562-16851D9F2636Q54117899-193A3FBF-06F8-4DCB-AA92-733B2FF8E783Q54637996-025DE4D0-6EC1-4804-8E8C-897F8C2C59FFQ55236425-8F49F24F-284F-4271-8090-E658089600FFQ57153235-E7B585A2-D064-4292-9251-434CD7D3B3D8Q58229736-AD90D859-5ACA-4385-B538-AF83F75324C2
P2860
Vascular actions of insulin with implications for endothelial dysfunction.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 02 June 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Vascular actions of insulin with implications for endothelial dysfunction.
@en
Vascular actions of insulin with implications for endothelial dysfunction.
@nl
type
label
Vascular actions of insulin with implications for endothelial dysfunction.
@en
Vascular actions of insulin with implications for endothelial dysfunction.
@nl
prefLabel
Vascular actions of insulin with implications for endothelial dysfunction.
@en
Vascular actions of insulin with implications for endothelial dysfunction.
@nl
P2093
P2860
P1476
Vascular actions of insulin with implications for endothelial dysfunction.
@en
P2093
Francesco Addabbo
Maria Assunta Potenza
Monica Montagnani
P2860
P304
P356
10.1152/AJPENDO.00297.2009
P577
2009-06-02T00:00:00Z